SEARCH

SEARCH BY CITATION

REFERENCES

  • Bjornsson TD, Callaghan JT, Einolf HJ, et al. (2003).The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. J Clin Pharmacol , 31: 815823.
  • Chen WK, Ju WZ (2009). Effects of Mailuoning injection on activity of rat CYPlA2, CYP2E1 and CYP3A4 by cocktail probe drugs. Chin. J Clin Pharmacol Ther, 14(4) : 386390.
  • Cho YA, Lee W, Choi JS (2012). Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin. Pharmazie, 67(2):124130.
  • Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS (2003). Short communication: Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CY P3A4 activity in normal volunteers. Drug Metab Dispos, 31(5): 519522.
  • Frye RF, Maltzke GR, Adedoyin A, Porter JA, and Branch RA (1997). Validation of five-drug ‘Pittsburgh cocktail’ approach for assessment of selective regulation of drug metabolizing enzymes. Clin Pharmacol Ther, 41:8084.
  • Gao J, Shi Z, Zhu S, Li GQ, Yan R, Yao M. (2013). Influences of processed rhubarbs on the activities of four CYP isozymes and the metabolism of saxagliptin in rats based on probe cocktail and pharmacokinetics approaches. J Ethnopharmacol 145(2):566572.
  • Han YL, Li D, Ren B, et al. (2012). Evaluation of impact of Herba Erigerontis injection a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. J Ethnopharmacol, 139: 104109.
  • Lee CK, Choi JS, Choi DH (2012). Effects of pravastatin on the pharmacokinetic parameters of nimodipine after oral and intravenous administration in rats: possible role of CYP3A4 inhibition by pravastatin. Indian J Pharmacol, 44(5):624628.
  • Li C, Kim M, Choi H, Choi J (2011). Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome p450 3A4 and P-glycoprotein inhibition by baicalein. Arch Pharm Res, 34(11): 19651972.
  • Malati CY, Robertson SM, Hunt JD, et al. (2012). Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J Clin Pharmacol, 52(6):932939.
  • Pandit S, Mukherjee PK, Ponnusankar S, Venkatesh M, Srikanth N (2011). Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia, 82: 369374.
  • Sharma A, Pilote S, Bélanger PM, Arsenault M, Hamelin BA (2004). A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes a pilot study. Br J Clin Pharmacol, 58(3):288297.
  • Venkataramanan R, Komoroski B, Strom S (2006). In vitro and in vivo assessment of herb drug interactions. Life Sci, 78: 21052115.
  • Yao YM, Cao W, Cao YJ, et al. (2007). Effect of sinomenine on human cytochrome P450 activity. Clin Chim Acta, 379(1–2): 113118.